The global market for preventive vaccines and influenza vaccines is projected to reach billions of dollars by 2028 and 2030, respectively. Factors driving the demand include the prevalence of infectious diseases, technological advancements, government support, and increasing awareness. Major players in the market include AstraZeneca, Emergent BioSolutions, GSK, Merck, Pfizer, Sanofi, Johnson & Johnson, Novavax, Daiichi Sankyo, and Takeda Pharmaceutical. The market is also witnessing trends such as the adoption of genetically engineered vaccines, rising demand for companion animal vaccines, and advancements in vaccine delivery systems.

Vaccine Market Projections